Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by VoxSolison Nov 24, 2016 9:39am
107 Views
Post# 25507533

A little perspective

A little perspectiveLifestyle Delivery Systems Inc. announces Memorandum of Understanding for distribution of CannaStrips to Hundreds of Dispensaries in California 22 Nov 2016 - ACQUIREMEDIA VANCOUVER, British Columbia, Nov. 22, 2016 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF), and Borse Frankfurt Exchange (XETR: LD6) ("LDS" or the "Company") is very pleased to announce that it has entered into a Memorandum of Understanding (the "MOU") with Azonic Health Sciences, LLC ("Azonic") and its affiliated companies for the distribution of its CannaStrips line of products. The arrangement would place CannaStrips in hundreds of current medical marijuana dispensaries and into the anticipated new retail stores throughout California. Brad Eckenweiler, CEO of Lifestyle Delivery Systems states, "The passage of Proposition 64 in the state of California legalizes the adult recreational use of cannabis for over 39 million residents and more than 100 million annual adult visitors. This is more than just a significant potential market increase, it represents more than 100 times the current number of legally registered medical marijuana users in the state that are now capable of purchasing CannaStrips. We also believe that the smokeless benefits of Cannastrips are ideally suited to the stringent California smoke free legislation, which restricts smoking of any kind in most public and commercial areas - a restriction that would not apply to CannaStrips. We are very excited for the prospects of offering the Lifestyle Delivery Systems' CannaStrips Technology to over 100 million possible new customers." The California market upon legalization will represent a market value greater than the rest of North America combined including Canada. The Company has recently made modifications to increase production capacity in anticipation of the expanded distribution network required to meet the projected 2017 market demand. About Azonic Health Sciences, LLC. Located in Simi Valley, CA, Azonic is an advertising, distribution and promotion company representing over 800 business and associations in the medical marijuana industry in California.
Bullboard Posts